It will enable us to bring to our patients the latest protocols developed at Sloan-Kettering, and help us build one of the finest cancer care facilities in this part of the world.
Gurgaon, India (PRWEB) October 1, 2009
Artemis Health Institute has entered into a partnership with New York-based Memorial Sloan-Kettering Cancer Center (MSKCC), one of the world's most renowned cancer centers. The partnership will focus on three core areas -- clinical care, research and training.
Already a leading center for the diagnosis and treatment of cancer in India, the partnership with MSKCC enables Artemis Health Institute (AHI) to provide Indian patients with access to the latest protocols in cancer care, and provides MSKCC with platform to enter the Indian market. Early efforts will center on physician exchanges, joint research on clinical trials and an international cancer symposium in Gurgaon early next year.
Speaking on the tie-up, Dr Robert E Wittes, Physician-In-Chief for Memorial Hospital, said: "We have a handful of such partnerships across the world now, including Artemis in India. We will be playing an advisory role to enable Artemis to build a world class cancer clinical care, research and training facility. Together, we plan to undertake clinical research projects, and share with Artemis the latest protocols in cancer care for their patients. I believe this will go a long way in establishing a leading cancer hospital in one of the largest healthcare destinations in the world."
According to a recent World Health Organization (WHO) study, India has some of the highest cancer rates in the world, particularly for oral, throat and gall bladder cancer. Urbanization and changes in diet and lifestyle are believed to be fueling higher cancers rates in India, which have traditionally been some of the lowest in the world.
Dr. Kushagra Katariya, CEO for Artemis Health Institute, remarked that the partnership with MSKCC would have far reaching impact in the diagnosis and treatment of cancer in India. "Our collaboration with Memorial Sloan-Kettering is exciting for two reasons," stated Dr. Katariya. "It will enable us to bring to our patients the latest protocols developed at Sloan-Kettering, and help us build one of the finest cancer care facilities in this part of the world."
Artemis and Memorial Sloan-Kettering plan to co-host their first International Oncology Conference in Gurgaon sometime in the second quarter of 2010 and will provide a unique opportunity for medical professionals in India and throughout the region to learn about new developments in the diagnosis and treatment of cancer from some of the world's leading experts.
For more information, please visit http://www.artemishospital.in/
About Memorial Sloan-Kettering Cancer Center
Founded in 1884, Memorial Sloan-Kettering in New York, USA, is synonymous with cancer care and treatment across the world. The Center is a multi-faceted institution which houses a premier biomedical research institute -- the Sloan-Kettering Institute; an excellent cancer hospital in the Memorial Hospital and a PhD programme in cancer biology through the Louis V Gerstner Jr Graduate School of Biomedical Sciences.
About Artemis Health Institute
Established in late 2007, Artemis Health Institute is a multi-speciality healthcare facility based in Gurgaon, India. Cancer is one of the three super specialties along with Cardiothoracic and Orthopedics. Artemis is a wholly-owned subsidiary of PTL Enterprises, promoted by Onkar S Kanwar and listed on the Bombay Stock Exchange. Dr Kushagra Katariya is the CEO of Artemis and its Chief Cardiothoracic Surgeon.